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Conclusion
Overall, the provisions on medical 
prescriptions in the Directive do safeguard 
patient safety. Yet, clear information and 
guidelines for pharmacists and prescribers 
on the legal framework are indispensable 
to ensure effective implementation.
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WHAT	INFORMATION	
DO	PATIENTS	WANT	
WHEN	CHOOSING	A	
HOSPITAL AT HOME 
OR ABROAD? A CASE 
STUDY FROM GERMANY
By: Michela Tinelli, Zlatko Nikoloski and Dimitra Panteli
Summary: The European Union (EU) is keen to promote patients’ 
rights, and to ensure that an informed choice is pursued when 
seeking health care in EU Member States. The 2011 Directive on the 
application of patients’ rights in cross-border health care is aimed at 
supporting the achievement of these goals. This article investigates 
German patients’ experience regarding their access and use of quality 
information when choosing hospital care in their own country and 
abroad. The findings could be used to inform the implementation of 
the Directive and the provision of quality information to patients, via 
the establishment of National Contact Points.
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Introduction
Ensuring patients have access to quality 
information is crucial to help them make 
informed choices, not only when they 
are in their home country, but also before 
going abroad for health care. One of the 
key objectives of the European Union's 
(EU) 2011 Directive on the application of 
patients’ rights in cross-border healthcare 
is to make sure that people have clear 
information on their rights to Cross-
Border Care and relevant knowledge on 
quality and safety standards enforced in 
the country of interest, as well as specific 
medical, organisational and financial 
aspects of the health care services and 
the treatment options on offer. 1  Such 
information should be provided by so-
called National Contact Points (NCPs) 
which are to be established in all Member 
States (MS). This case study investigated 
what type of information German patients 
accessed and what source they used when 
choosing a hospital for their care. Two 
scenarios were compared, one examining 
patients seeking care in their own country 
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and one investigating patients planning to 
receive care in another MS. Two separate 
patient surveys conducted in Germany in 
late 2012 were used for this purpose.
Scenario 1 – Patients seeking care in 
their own country
The Making Choice in Health Care 
Survey collected data from a series of 
EU countries, including Germany. 2 , 3  
A total of 128 German patients from 
two General Practitioner (GP) practices 
completed the survey whilst waiting for 
their consultation. They were asked about 
their personal experience of accessing 
information when choosing hospital 
care. Key findings are summarised in 
Table 1. Patients used different sources 
of information when making a decision 
on their hospital care, be it media (i.e. 
newspaper, internet or television), 
personal contacts (i.e. friends, family, or 
neighbours) or health care providers. The 
latter were reported as the preferred source 
of information compared with the others 
(health care professionals (74%), personal 
(3 – 21%), and media (5 – 12%)) for care 
received in Germany.
Patients were also interested in a variety 
of topics regarding their care, including 
health-related information such as quality 
standards (e.g. hospital performance or 
professional qualifications), safety (e.g. 
risk of treatment and infection rates) and 
organisation-related information (e.g. 
how to contact the health care provider 
and its location). Health-related and 
organisational-related information were 
equally important when making choices 
on hospital care (e.g. “professional 
qualifications” and “how to contact the 
health care providers” accounted for 65% 
of the responses).
Scenario 2 – Patients planning their 
care abroad
The Europa-Survey 2012 was designed 
by the Techniker Krankenkasse (TK) 
sickness fund in collaboration with the 
Berlin University of Technology to collect 
information from the 45,000 insured 
individuals who obtained services abroad 
and had them processed by the fund 
in 2010. 3  Of the 17,543 respondents, 
about 19% (3,307/17,543) reported having 
received planned care abroad, and 11% 
(1,888/17,543) indicated that they used 
cross-border services on a regular basis. 
The majority of those receiving planned 
care at a hospital abroad (mainly seeking 
care for musculoskeletal conditions, renal 
failure (dialysis), or cancer) were keen to 
access guidance on their rights to Cross-
Border Care (59%; see Table 1). They 
reported that health care professionals 
were used as sources of information 
more frequently than personal contacts or 
media (health care professionals (49%), 
personal (18%), media (22%)). Most 
respondents used services provided by the 
health insurer as a source of information 
before seeking hospital care abroad (62% 
contacted TK customer service;* 42% 
contacted the TK hotline†).
Information related to health (e.g. hospital 
performance (38%) and professional 
qualifications (41%)) and financial issues 
(e.g. coverage of costs by insurers (42%) 
and reimbursement modalities (49%)) 
was sought more frequently by patients 
compared with organisation-related 
information, in particular “language of 
staff” (7%).
Scenarios 1 and 2
For both patients seeking care in their 
own country (Scenario 1) and planning 
care abroad (Scenario 2) health care 
professionals were reported as a preferred 
source of information compared with 
personal contacts or media. When looking 
* Local contact points for those insured by the TK; they 
can be contacted by phone or visited by appointment. 
† 24/7 hotline providing information on TK services free 
for national calls; however, it can also be reached from 
outside Germany. 
Table 1: Sources and types of information sought by patients when seeking hospital care at home and abroad
Scenario 1
Hospital care in their home country
(Making Choice in Health Care Survey; 
percentage of responses)
Scenario 2
Planned Hospital care abroad
(The Europa-Survey 2012;  
percentage of responses)
Source of information 
Media (Newspaper/Internet/Television) 12 / 20 / 5 3 / 19 / n.a.
Personal (Friends/Family/Neighbours) 21 / 20 / 3 18
Health care providers 74 40
Health insurers (TK customer service/TK hotline) n.a. 62 / 42
Type of information 
Health-related  
Professional qualifications  
Risk of treatment/Rates of infection.  
Quality of medical care/Hospital performance
 
65 
57 
47
 
41 
3 
38
Organisational-related (How to contact the health care 
provider/Location/ Language staff) 
65 / 50 / n.a. n.a. / n.a. / 7
Financial-related (Savings, Coverage of costs by insurer, 
Reimbursement modalities) 
n.a. 7 / 42 / 49
Source: Authors. Note: n.a = not available as the survey did not collect this particular information. 
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at the type of information accessed, 
health-related and organisation-related 
information were valued by resident 
patients, whilst patients seeking care 
abroad valued information related to 
health and financial issues (see Table 1).
Results from the German case study 
showed that patients do value the support 
received by health care providers and 
health care insurers when making choices 
about health care, and want to access clear 
information about their rights to Cross-
Border Care when planning to obtain 
care abroad. On the basis of the German 
case study more effort should be made to 
help patients seeking treatment in another 
MS to make contact with the health care 
providers from the MS of treatment, and to 
inform the referring health care providers 
in their home country about the potential 
health care opportunities of patients 
when they go abroad. According to the 
Directive, health insurers from the MS 
of treatment are not expected to provide 
information to patients coming from other 
MS, although evidence suggests that 
they do so for their own patients when 
the latter seek care abroad. In addition, 
whether health care providers in the MS 
of treatment are already used to sharing 
quality information with resident patients 
may have an impact when supporting 
patients to make informed choices about 
health care available in another MS.
Conclusion
Despite differences in the survey 
instruments adopted to describe the two 
separate scenarios, it is confirmed that 
both resident and cross-border patients 
want to be informed on multiple health-
related aspects of care, most of them 
equally important between the two groups. 
Surprisingly, patients seem to be more 
worried about the risk of treatment and 
infection rates when receiving care in 
their home country than when seeking 
care abroad. As expected, patients going 
abroad are more likely to seek information 
on financial issues from their health 
insurer, whilst patients looking for hospital 
treatment domestically, in principle, 
should already have this information. 
The detailed results of the case study 
could inform possible challenges and 
opportunities when setting up NCPs 
in MSs.
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This	new	book	explores	some	of	the	innovative	strategies	
being	deployed	against	cancer	in	Europe	and	how	
international	collaboration	has	assisted	in	combating	the	
cancer	burden.	The	research	is	a	product	of	the	European	
Partnership	for	Action	Against	
Cancer	(EPAAC)	and	it	highlights	
some	outstanding	examples	of	
how	cooperation	between	
national	and	international	entities,	
as	well	as	policy-oriented	
innovation,	are	contributing	to	
the	collective	effort	
to control cancer.
